|
|
Volumn 207, Issue 4, 2013, Pages 547-549
|
|
The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
ENZYME INHIBITOR;
SIALIDASE;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H1N1;
MORTALITY;
NOTE;
PANDEMIC;
ANTIVIRAL AGENTS;
ENZYME INHIBITORS;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
NEURAMINIDASE;
PANDEMICS;
|
|
EID: 84876074745
PISSN: None
EISSN: 15376613
Source Type: Journal
DOI: 10.1093/infdis/jis727 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
